Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: post hoc subanalysis of the randomized, phase 3 PROPEL study
Escuriola-Ettingshausen, Carmen, Klamroth, Robert, Escobar, Miguel, Stasyshyn, Oleksandra, Tangada, Srilatha, Engl, Werner, Honauer, Ivan, Lee, Hye-Youn, Chowdary, Pratima, Windyga, Jerzy
Published in Therapeutic advances in hematology (01.01.2023)
Published in Therapeutic advances in hematology (01.01.2023)
Get full text
Journal Article
Targeting an elevated FVIII level using personalized rurioctocog alfa pegol prophylaxis in specific patient populations with hemophilia A: subanalysis of the randomized, phase 3 PROPEL study
Carmen Escuriola-Ettingshausen, Robert Klamroth, Miguel Escobar, Oleksandra Stasyshyn, Srilatha Tangada, Werner Engl, Ivan Honauer, Hye-Youn Lee, Pratima Chowdary, Jerzy Windyga
Published in Therapeutic advances in hematology (01.06.2023)
Published in Therapeutic advances in hematology (01.06.2023)
Get full text
Journal Article